Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Simonetta, Federico  [Clear All Filters]
2024
Pagliuca S, Schmid C, Santoro N, Simonetta F, Battipaglia G, Guillaume T, Greco R, Onida F, Sánchez-Ortega I, Yakoub-Agha I, et al. Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT. Lancet Haematol. 2024;11(6):e448-e458.
Bernardi C, Charvet C, Zeiser R, Simonetta F. GM-CSF in Allogenic Hematopoietic Stem Cell Transplantation: from Graft-versus-Host Disease to Graft-versus-Tumor effect. Transplant Cell Ther. 2024.
Giannotti F, Ortiz CDe Ramón, Simonetta F, Morin S, Bernardi C, Masouridi-Levrat S, Chalandon Y, Mamez A-C. Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report. Front Immunol. 2024;15:1360275.
Garaudé S, Marone R, Lepore R, Devaux A, Beerlage A, Seyres D, Aglio ADell', Juskevicius D, Zuin J, Burgold T, et al. Selective haematological cancer eradication with preserved haematopoiesis. Nature. 2024.
2023
Sollet ZCalderin, Schäfer A, Ferrari-Lacraz S, Masouridi-Levrat S, Mamez A-C, Pradier A, Simonetta F, Chalandon Y, Villard J, Buhler S. CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation. Leukemia. 2023.
Marone R, Landmann E, Devaux A, Lepore R, Seyres D, Zuin J, Burgold T, Engdahl C, Capoferri G, Dell'Aglio A, et al. Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy. J Exp Med. 2023;220(12).
Maas-Bauer K, Köhler N, Stell A-V, Zwick M, Acharya S, Rensing-Ehl A, König C, Kroll J, Baker J, Koßmann S, et al. Single-cell Transcriptomics Reveal Different Maturation Stages and Sublineages Commitment of Human Thymic Invariant Natural Killer T cells. J Leukoc Biol. 2023.
2022
Chalandon Y, Mamez A-C, Giannotti F, Beauverd Y, Dantin C, Mahne E, Mappoura M, Bernard F, Ortiz Cde Ramon, Stephan C, et al. DEFIBROTIDE SHOWS EFFICACY IN THE PREVENTION OF SINUSOIDAL OBSTRUCTION SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE STUDY ON 237 PATIENTS. Transplant Cell Ther. 2022.
Ramos TLopes, Bolivar-Wagers S, Jin S, Thangavelu G, Simonetta F, Lin P-Y, Hirai T, Saha A, Koehn BH, Su LL, et al. Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo. Blood. 2022.